Deutsche Bank Aktiengesellschaft Reaffirms “Buy” Rating for ConvaTec Group (LON:CTEC)

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reissued by equities researchers at Deutsche Bank Aktiengesellschaft in a research report issued to clients and investors on Wednesday,London Stock Exchange reports. They presently have a GBX 315 target price on the stock. Deutsche Bank Aktiengesellschaft’s price objective points to a potential upside of 40.12% from the stock’s previous close.

A number of other brokerages have also recently issued reports on CTEC. Citigroup reiterated an “outperform” rating and set a GBX 315 target price on shares of ConvaTec Group in a research report on Thursday, March 5th. Stifel Nicolaus reiterated a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research report on Wednesday, March 11th. Finally, Berenberg Bank increased their target price on shares of ConvaTec Group from GBX 330 to GBX 340 and gave the stock a “buy” rating in a research report on Thursday, January 22nd. Eight investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of GBX 319.

ConvaTec Group Price Performance

Shares of CTEC traded up GBX 10.40 during mid-day trading on Wednesday, reaching GBX 224.80. The company had a trading volume of 37,214,527 shares, compared to its average volume of 15,950,142. ConvaTec Group has a twelve month low of GBX 209.40 and a twelve month high of GBX 311.20. The company has a debt-to-equity ratio of 106.19, a current ratio of 1.53 and a quick ratio of 0.96. The company’s 50-day moving average is GBX 230.62 and its 200-day moving average is GBX 235.04. The company has a market capitalization of £4.39 billion, a P/E ratio of 26.14, a P/E/G ratio of 0.93 and a beta of 0.76.

Insiders Place Their Bets

In related news, insider Jonny Mason sold 291,149 shares of the firm’s stock in a transaction on Monday, March 16th. The stock was sold at an average price of GBX 234, for a total transaction of £681,288.66. 0.95% of the stock is owned by corporate insiders.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.